CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 270.1	$ 325.0
Short-term investments		114.2
Accounts receivable, net	323.4	319.3
Inventories	518.6	486.2
Other current assets	149.4	114.1
Total current assets	1,261.5	1,358.8
Property, plant and equipment, net	260.9	266.5
Goodwill	199.9	169.8
Intangibles, net and other long-term assets	166.8	153.4
Total assets	1,889.1	1,948.5
Current liabilities:
Current portion of long-term debt	15.4
Accounts payable	100.0	90.8
Customer advances	110.4	111.7
Other current liabilities	337.3	322.0
Total current liabilities	563.1	524.5
Long-term debt	225.2	415.6
Other long-term liabilities	275.6	274.9
Commitments and contingencies (Note 13)
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding
Common stock, $0.01 par value 260,000,000 shares authorized, 172,537,082 and 171,875,076 shares issued and 156,512,202 and 155,865,977 shares outstanding at September 30, 2018 and December 31, 2017, respectively	1.7	1.7
Treasury stock, at cost, 16,024,880 and 16,009,099 shares at September 30, 2018 and December 31, 2017, respectively	(401.5)	(401.2)
Accumulated other comprehensive income	12.7	27.0
Other shareholders' equity	1,204.0	1,097.9
Total shareholders' equity attributable to Bruker Corporation	816.9	725.4
Noncontrolling interest in consolidated subsidiaries	8.3	8.1
Total shareholders' equity	825.2	733.5
Total liabilities and shareholders' equity	$ 1,889.1	$ 1,948.5